Home / Management & Operations / New Therapy Helps Prevent Spread of Nightmare Bacteria

New Therapy Helps Prevent Spread of Nightmare Bacteria

BROOKLYN, NY–A recent USA Today article reported The Centers for Disease Control and Prevention detected more than 220 cases last year of a rare breed of “nightmare bacteria” that are virtually untreatable and capable of spreading genes that make them impervious to most antibiotics. This nightmare bacteria is particularly deadly in seniors and people with chronic illnesses.

REZair™ is a flagship general wellness skin-aeration product line of devices that works for both adult and infant patients. “Pressure ulcers present grave implications for both patients and the health facilities that care for them,” founder Nigel Parker says. “It’s incumbent on all hospitals, nursing homes and other health facilities to prevent them; and help prevent the spread of bacteria.”

REZair™ is exceptionally safe for the patient, simple and easy to use for the clinician, efficacious in treating the root causes of several diagnoses, and financially beneficial to all care providers.

Parker, founder and CEO of RashEndZ Inc., is a senior management and systems engineer professional with more than 25 years experience in aerospace, medical simulation and other high-tech industries. While working at Honeywell from 1984 to 2001, he worked on the space shuttle, military aircraft and commercial aircraft, among other projects.

Parker is the inventor of REZair, a skin-aeration liner that can be inserted inside a diaper, incontinence garment or wound dressing. The liner connects to any air/oxygen source and circulates air or oxygen on rashes, helping to keep the skin dry and speed healing.